A Study of CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma
NCT05325801
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
BMCA and GPRC5D dual target CAR-T cells(OriC321)
Sponsor
Zhejiang University